Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels in acromegaly patients in remission

BACKGROUND/AIM: Acromegaly is associated with increased morbidity and mortality, mostly due to cardiovascular complications. Plasma thrombin-activatable fibrinolysis inhibitor (TAFI) antigen levels are associated with coagulation/fibrinolysis and inflammation. Plasma TAFI may play a role in arterial...

Descripción completa

Detalles Bibliográficos
Autores principales: ERDOĞAN, Mehmet, ÖZBEK, Mustafa, AKBAL, Erdem, ÜRETEN, Kemal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018305/
https://www.ncbi.nlm.nih.gov/pubmed/31549496
http://dx.doi.org/10.3906/sag-1812-231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7018305/
https://www.ncbi.nlm.nih.gov/pubmed/31549496
http://dx.doi.org/10.3906/sag-1812-231

Ejemplares similares